1. Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis

   • Amir Masoud Afsahi
   • Alexander M. Norbash
   • Sam Sedaghat

   Review 03 August 2023 Pages: 5131 - 5154

   

2. Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis

   • Lily Devlin
   • Grace Y. Gombolay

   Review 15 August 2023 Pages: 5155 - 5161

   

3. Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions

   • Ettore Beghi
   • Andrei Ivashynka
   • Yun Jin Kim

   Review 08 September 2023 Pages: 5162 - 5170

4. Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review

   • Chang Geng
   • Weili Zhao
   • Hongzhi Guan

   Review 11 September 2023 Pages: 5171 - 5181

   

5. Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results

   • Jonathan P. Rogers
   • Michael K. L. Chou
   • Michael S. Zandi

   Short Commentary Open access 22 September 2023 Pages: 5182 - 5187

   

6. Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group‏ Viewpoint

   • Panayiota Petrou
   • Anat Achiron
   • Dimitrios Karussis

   Original Communication 12 July 2023 Pages: 5188 - 5195

   

7. Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim

   • Paula Lombardo-del Toro
   • Irene Bragado-Trigo
   • Lucía Romero-Pinel

   Letter to the Editors 17 July 2023 Pages: 5196 - 5200

   

8. Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR

   • Samantha Noteboom
   • D. R. van Nederpelt
   • M. M. Schoonheim

   Original Communication Open access 19 July 2023 Pages: 5201 - 5210

   

9. Multiple sclerosis lesions that impair memory map to a connected memory circuit

   • Isaiah Kletenik
   • Alexander L. Cohen
   • Michael D. Fox

   Original Communication 02 August 2023 Pages: 5211 - 5222

   

10. Cortical thickness and cognition in older people with multiple sclerosis

    • Dejan Jakimovski
    • Robert Zivadinov
    • Ralph H. B. Benedict

    Original Communication 27 August 2023 Pages: 5223 - 5234

    

11. Sex-related differences in upper limb motor function in healthy subjects and multiple sclerosis patients: a multiparametric MRI study

    • Raffaello Bonacchi
    • Paola Valsasina
    • Massimo Filippi

    Original Communication 28 August 2023 Pages: 5235 - 5250

    

12. Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions

    • BaoLing Chen
    • Wanlin Yang
    • Qing Wang

    Review 21 July 2023 Pages: 5251 - 5273

    

13. Role of expectations in clinical outcomes after deep brain stimulation in patients with Parkinson’s disease: a systematic review

    • Francesca Mameli
    • Eleonora Zirone
    • Fabiana Ruggiero

    Review Open access 30 July 2023 Pages: 5274 - 5287

    

14. Movement disorders in autoimmune encephalitis: an update

    • Mengting Qin
    • Jiaojiao Chen
    • Ling Mao

    Review 31 July 2023 Pages: 5288 - 5302

15. Acquired bilateral facial palsy: a systematic review on aetiologies and management

    • Giulia Molinari
    • Daniela Lucidi
    • Matteo Alicandri-Ciufelli

    Review Open access 31 July 2023 Pages: 5303 - 5312

    

16. Machine learning for adaptive deep brain stimulation in Parkinson’s disease: closing the loop

    • Andreia M. Oliveira
    • Luis Coelho
    • Paulo Aguiar

    Review Open access 02 August 2023 Pages: 5313 - 5326

    

17. The effects of exercise dose on patients with Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials

    • Wenlai Cui
    • Dong Li
    • Jun Xie

    Review 02 August 2023 Pages: 5327 - 5343

    

18. Retrospective observational study on the use of acetyl-l-carnitine in ALS

    • Serena Sassi
    • Elisa Bianchi
    • Elisabetta Pupillo

    Original Communication Open access 28 June 2023 Pages: 5344 - 5357

    

19. Correction to: Retrospective observational study on the use of acetyl-l-carnitine in ALS

    • Serena Sassi
    • Elisa Bianchi
    • Elisabetta Pupillo

    Correction Open access 08 September 2023 Pages: 5358 - 5359

20. Neural patterns of conscious visual awareness in the Riddoch syndrome

    • Ahmad Beyh
    • Samuel E. Rasche
    • Semir Zeki

    Original Communication Open access 10 July 2023 Pages: 5360 - 5371

    

21. Efficacy of cerebellar transcranial magnetic stimulation in spinocerebellar ataxia type 3: a randomized, single-blinded, controlled trial

    • Yuting Shi
    • Guangdong Zou
    • Hong Jiang

    Original Communication 11 July 2023 Pages: 5372 - 5379

    

22. Comprehensive pathological and genetic investigation of three young adult myotonic dystrophy type 1 patients with sudden unexpected death

    • Yukiko Hata
    • Shojiro Ichimata
    • Naoki Nishida

    Original Communication 11 July 2023 Pages: 5380 - 5391

    

23. Cerebral lesions sites in neurosarcoidosis: a lesion mapping study

    • Kilian Fröhlich
    • Anne Mrochen
    • Klemens Winder

    Original Communication Open access 12 July 2023 Pages: 5392 - 5397

    

24. Evaluation of myotonometry for myotonia, muscle stiffness and elasticity in neuromuscular disorders

    • Katharina Lukas
    • Kristina Gutschmidt
    • Stephan Wenninger

    Original Communication Open access 17 July 2023 Pages: 5398 - 5407

    

25. Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments

    • Andrea Horta-Barba
    • Saul Martinez-Horta
    • the Cognitive Phenotype Working Group of the European Huntington’s Disease Network

    Original Communication Open access 18 July 2023 Pages: 5408 - 5417

    

26. Longitudinal changes in qualitative aspects of semantic fluency in presymptomatic and prodromal genetic frontotemporal dementia

    • Lize C. Jiskoot
    • Esther van den Berg
    • Harro Seelaar

    Original Communication Open access 18 July 2023 Pages: 5418 - 5435

    

27. Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study

    • Fabrizio Vernieri
    • Nicoletta Brunelli
    • Claudia Altamura

    Original Communication 19 July 2023 Pages: 5436 - 5448

    

28. Disability in cerebellar ataxia syndromes is linked to cortical degeneration

    • Julian Conrad
    • Anna Huppert
    • Peter zu Eulenburg

    Original Communication Open access 22 July 2023 Pages: 5449 - 5460

    

29. Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease

    • Yasuaki Mizutani
    • Reiko Ohdake
    • Hirohisa Watanabe

    Original Communication Open access 22 July 2023 Pages: 5461 - 5474

    

30. Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis

    • Rosario Vasta
    • S. Callegaro
    • A. Calvo

    Original Communication Open access 25 July 2023 Pages: 5475 - 5482

    

31. Inclusion body myositis with early onset: a population-based study

    • Ulrika Lindgren
    • Carola Hedberg-Oldfors
    • Anders Oldfors

    Original Communication Open access 27 July 2023 Pages: 5483 - 5492

    

32. Pre-treatment risk markers for hemorrhagic transformation in posterior circulation acute ischemic stroke treated with reperfusion therapy

    • Claire Ancelet
    • Sophie Neveü
    • Christian Denier

    Original Communication 29 July 2023 Pages: 5493 - 5501

    

33. Differentiating between common PSP phenotypes using structural MRI: a machine learning study

    • Andrea Quattrone
    • Alessia Sarica
    • Aldo Quattrone

    Original Communication Open access 29 July 2023 Pages: 5502 - 5515

    

34. Prognosis of vestibular dysfunction in idiopathic sudden sensorineural hearing loss with vertigo: a prospective cohort study

    • Weiming Hao
    • Lei Ye
    • Huawei Li

    Original Communication 30 July 2023 Pages: 5516 - 5526

    

35. Characteristics of primary Sjögren’s syndrome-associated peripheral nervous system lesions

    • Jiaman Zheng
    • Jiayu Zhang
    • Chao Yuan

    Original Communication 31 July 2023 Pages: 5527 - 5535

    

36. The cysteine-altering p.R544C variant in the NOTCH3 gene is a probable candidate for blood pressure and relevant traits in the Taiwan Biobank

    • Eugene Lin
    • Po-Hsiu Kuo
    • Shih-Jen Tsai

    Original Communication 01 August 2023 Pages: 5536 - 5544

37. Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease

    • Julian Theuriet
    • Florent Cluse
    • Antoine Pegat

    Original Communication Open access 04 August 2023 Pages: 5545 - 5560

    

38. Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease

    • Marta Bellofatto
    • Luca Gentile
    • for the Italian C. M. T. Network

    Original Communication Open access 04 August 2023 Pages: 5561 - 5568

39. Correction to: Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease

    • Marta Bellofatto
    • Luca Gentile
    • for the Italian C. M. T. Network

    Correction Open access 21 September 2023 Pages: 5569 - 5570

40. Clinical features and recovery pattern of secondary hypokalaemic paralysis

    • Akiyuki Hiraga
    • Kazuho Kojima
    • Satoshi Kuwabara

    Original Communication 04 August 2023 Pages: 5571 - 5577

    

41. Left ventricular hypertrophy and left atrial size are associated with ischemic strokes among non-vitamin K antagonist oral anticoagulant users

    • Alvin S. Das
    • Elif Gökçal
    • M. Edip Gurol

    Original Communication 07 August 2023 Pages: 5578 - 5588

    

42. Anxiety and physical impairment in patients with central vestibular disorders

    • Lena Padovan
    • Sandra Becker-Bense
    • Marianne Dieterich

    Original Communication Open access 08 August 2023 Pages: 5589 - 5599

    

43. The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)

    • Massimo Filippi
    • Roberta Messina
    • RESET BRAIN Study Group

    Original Communication Open access 08 August 2023 Pages: 5600 - 5612

    

44. Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease

    • Fabrizio Angius
    • Ignazia Mocci
    • Anna R. Carta

    Short Commentary Open access 08 August 2023 Pages: 5613 - 5621

    

45. Susceptibility to brain ischemia and the association between migraine and spontaneous cervical artery dissection

    • Elisabetta Del Zotto
    • Mario Grassi
    • The Italian Project on Stroke in Young Adults—Cervical Artery Dissection (IPSYS CeAD) Research Group

    Letter to the Editors 12 July 2023 Pages: 5622 - 5628

46. 4-Aminopyridine improves real-life gait performance in SCA27B on a single-subject level: a prospective n-of-1 treatment experience

    • Jens Seemann
    • Andreas Traschütz
    • Matthis Synofzik

    Letter to the Editors Open access 13 July 2023 Pages: 5629 - 5634

    

47. Menière’s disease with migraine, Menière’s disease without migraine and Vestibular migraine: clinical differences

    • Gülden Akdal
    • Tural Tanrıverdizade
    • Günay Kırkım

    Letter to the Editors 15 July 2023 Pages: 5635 - 5638

    

48. Crossing the border between epileptic and vascular pathology: a report of CACNA1A-related treatment-resistant hemiplegic migraine

    • M. Rubin
    • G. Cutillo
    • B. Colombo

    Letter to the Editors 19 July 2023 Pages: 5639 - 5644

    

49. Typewriter tinnitus with time-locked vestibular paroxysmia in a patient with cerebellopontine angle meningioma

    • Yuzhong Zhang
    • Marcus L. F. Janssen
    • Raymond van de Berg

    Letter to the Editors Open access 21 July 2023 Pages: 5645 - 5648

    

50. Seroprevalence of autoimmune antibodies in degenerative ataxias: a broad, disease-controlled screening in 456 subjects

    • Benjamin Roeben
    • Madeleine Scharf
    • Matthis Synofzik

    Letter to the Editors Open access 28 July 2023 Pages: 5649 - 5654